Evidence map›Paper›PMID 21283770›Full record

ArticlePloS one2011

ReCLIP (reversible cross-link immuno-precipitation): an efficient method for interrogation of labile protein complexes.

Andrew L Smith, David B Friedman, Huapeng Yu, Robert H Carnahan, Albert B Reynolds

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Protocol forSTAR protocols · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. ROCK1 inhibitor stabilizes E-cadherin and improves barrier function in experimental necrotizing enterocolitis.American journal of physiology. Gastrointestinal and liver physiology · 2020
    Article
  20. Preserving Single Cells in Space and Time for Analytical Assays.Trends in analytical chemistry : TRAC · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrew L SmithDepartment of Cancer Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
David B Friedman
Huapeng Yu
Robert H Carnahan
Albert B Reynolds

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
PL20 AND CELL CELL ADHESIONR01CA055724 · NCI · VANDERBILT UNIVERSITY · PI REYNOLDS, ALBERT B · 1997 to 2010
$2.9M
A mouse model for p120 downregulation in cancerR01CA111947 · NCI · VANDERBILT UNIVERSITY · PI REYNOLDS, ALBERT B · 2005 to 2009
$1.7M
NCI NIH HHS 50 CA95103)NCI NIH HHS P30 CA068485NCI NIH HHS P30-CA068485NCI NIH HHS P50 CA095103NCI NIH HHS R01 CA055724NCI NIH HHS R01 CA111947NCI NIH HHS R01 CA55724
6 · The paper itself

Abstract

The difficulty of maintaining intact protein complexes while minimizing non-specific background remains a significant limitation in proteomic studies. Labile interactions, such as the interaction between p120-catenin and the E-cadherin complex, are particularly challenging. Using the cadherin complex as a model-system, we have developed a procedure for efficient recovery of otherwise labile protein-protein interactions. We have named the procedure "ReCLIP" (Reversible Cross-Link Immuno-Precipitation) to reflect the primary elements of the method. Using cell-permeable, thiol-cleavable crosslinkers, normally labile interactions (i.e. p120 and E-cadherin) are stabilized in situ prior to isolation. After immunoprecipitation, crosslinked binding partners are selectively released and all other components of the procedure (i.e. beads, antibody, and p120 itself) are discarded. The end result is extremely efficient recovery with exceptionally low background. ReCLIP therefore appears to provide an excellent alternative to currently available affinity-purification approaches, particularly for studies of labile complexes.

Indexed as

Cross-Linking ReagentsImmunoprecipitationMethodsMultiprotein ComplexesProtein StabilitySulfhydryl CompoundsCross-Linking ReagentsMultiprotein ComplexesSulfhydryl Compounds

Identifiers

PMID21283770
PMCPMC3024417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.